Latest News from: Dana-Farber Cancer Institute

Filters close
Released: 21-Feb-2007 5:05 PM EST
Study Confirms Normal Patterns of Grief, Highlights Yearning
Dana-Farber Cancer Institute

"Is my grief normal?" That is one of the most common questions posed by people who have lost a loved one. A new study by Dana-Farber researchers has helped answer that question by affirming the commonly accepted stages of grief "“ disbelief, yearning, anger, depression, and acceptance "“ and the sequence in which these emotions occur. The findings will appear in the Feb. 21 issue of the Journal of the American Medical Association (JAMA).

Released: 20-Feb-2007 11:00 AM EST
A Wedding Gift that Helps Save Lives
Dana-Farber Cancer Institute

Dana-Farber Cancer Institute is offering wedding party favors that help fight cancer. Couples getting married can honor their guests by making a donation to Dana-Farber's Jimmy Fund, which supports adult and pediatric cancer care and research. The donation will be noted on table cards or scrolls, which can be placed on tables at the wedding reception.

Released: 25-Jan-2007 3:00 PM EST
Gene Knockouts Reveal FoxOs’ Vital Functions in Cancer Defense, Health of Stem Cells
Dana-Farber Cancer Institute

In an elegant, multiple-gene knockout experiment, a team of Boston scientists has discovered that a trio of molecules, called FoxOs, are fundamentally critical in preventing some cancers, maintaining blood vessel stability, and in keeping blood-forming stem cells healthy.

10-Jan-2007 7:35 PM EST
Study Finds Variations in Oral Chemo Safeguards
Dana-Farber Cancer Institute

Despite the widespread use of prescribing safeguards for infusion chemotherapy, few of those measures have been implemented with oral chemotherapy, according to a study led by researchers at Dana-Farber Cancer Institute.

Released: 9-Jan-2007 2:45 PM EST
Why Doesn’t the Immune System Attack the Small Intestine?
Dana-Farber Cancer Institute

Answering one of the oldest questions in human physiology, researchers at Dana-Farber Cancer Institute have discovered why the body's immune system "“ perpetually on guard against foreign microbes like bacteria "“ doesn't attack tissues in the small intestine that harbor millions of bacteria cells.

14-Dec-2006 4:55 PM EST
One in Five Breast Cancer Patients May Not Adhere to Hormone Therapy
Dana-Farber Cancer Institute

Postmenopausal women with early-stage, hormone-sensitive breast cancer have a lower risk of disease recurrence when their treatment includes a new class of hormone therapy drugs, yet one out five women prescribed the drugs may not take them regularly.

8-Dec-2006 9:35 PM EST
Drug Combination Proves Effective Against Myeloma in Phase I Trial
Dana-Farber Cancer Institute

Two "new generation" drugs for the bone marrow cancer multiple myeloma may work even better together than they do individually, according to the results of a multicenter Phase I clinical trial to be presented by Dana-Farber Cancer Institute scientists at the annual meeting of the American Society of Hematology in Orlando, Fla.

Released: 5-Dec-2006 4:55 PM EST
Blacks Less Likely to Recognize Overweight and Obesity
Dana-Farber Cancer Institute

Overweight black Americans are two to three times more likely than heavy white Americans to say they are of average weight "“ even after being diagnosed as overweight or obese by their doctors, according to a new study led by Dana-Farber Cancer Institute researchers.

16-Oct-2006 3:35 PM EDT
Scientists ID Switch for Brain's Natural Anti-Oxidant Defense
Dana-Farber Cancer Institute

Scientists at Dana-Farber Cancer Institute report they have found how the brain turns on a system designed to protect its nerve cells from toxic "free radicals," a waste product of cell metabolism that has been implicated in some degenerative brain diseases, heart attacks, strokes, cancer, and aging.

Released: 5-Oct-2006 9:10 PM EDT
Dana-Farber Offers Online Resources for Breast Cancer Patients and Families
Dana-Farber Cancer Institute

Recognizing breast cancer patients' desire to stay informed about the advances in medical research today and the shortcomings of many breast cancer web sites, Dana-Farber Cancer Institute has developed a Web site that provides accurate information on breast cancer care and research for patients, as well as their family and friends.

Released: 2-Oct-2006 2:25 PM EDT
Molecular Atlas Provides New Tool for Understanding Estrogen-Fueled Breast Cancer
Dana-Farber Cancer Institute

Dana-Farber investigators have developed the first complete map of the molecular "control panels" operated by the cells' estrogen receptor, the master regulator of cell growth in the most common form of breast cancer. This may eventually help doctors match patients with treatments that are most likely to be effective and overcome the problem of resistance to current hormone therapies.

15-Sep-2006 3:50 PM EDT
Insight Into Tanning Process Suggests Novel Way to Prevent Skin Cancer
Dana-Farber Cancer Institute

Findings from a study led by researchers at Dana-Farber Cancer Institute and Children's Hospital Boston have rewritten science's understanding of the process of skin tanning "“ an insight that has enabled them to develop a promising way of protecting fair-skinned people from skin cancer caused by exposure to sunlight.

12-Aug-2006 2:05 PM EDT
Adverse Effects and Costs of Chemotherapy Greater than Previously Thought
Dana-Farber Cancer Institute

Researchers at Dana-Farber Cancer Institute and Harvard Medical School have found that breast cancer patients 63 years of age or younger may experience more chemotherapy-related serious adverse effects than reported in clinical trials, according to a new study in the August 16 issue of the Journal of the National Cancer Institute.

25-Jul-2006 2:10 PM EDT
Study Suggests TV-watching Lowers Physical Activity
Dana-Farber Cancer Institute

A study of low-income housing residents has documented that the more television people say they watched, the less active they were, researchers from Dana-Farber Cancer Institute and colleagues report. The findings of television's effects on physical activity are the first to be based on objective measurements using pedometers, rather than the study subjects' memories of their physical activity.

Released: 17-Jul-2006 3:35 PM EDT
Scientists Isolate Leukemia Stem Cells in Mouse Model
Dana-Farber Cancer Institute

Researchers at Dana-Farber Cancer Institute and Children's Hospital Boston have isolated rare cancer stem cells that cause leukemia in a mouse model of the human disease. The leukemia stem cells isolated proved to be surprisingly different from normal blood stem cells -- a finding that may be good news for developing a drug that selectively targets them.

27-Jun-2006 7:10 PM EDT
Mouse Model Aids Discovery of Novel Melanoma Metastasis Gene
Dana-Farber Cancer Institute

Researchers from Dana-Farber Cancer Institute have identified a novel gene that facilitates the spread of malignant melanoma, a life-threatening skin cancer, using a technique they say can speed the discovery of hard-to-find cancer genes.

Released: 12-Jun-2006 1:40 PM EDT
Scientists Tie Several Cancers to Common “Oncogene Engine”
Dana-Farber Cancer Institute

Researchers at Dana-Farber Cancer Institute report that a common "oncogene engine" "“ a small family of malfunctioning cell growth switches "“ drives several seemingly unrelated, lethal forms of cancer, including malignant melanoma. The finding suggests that it may be possible to attack these different cancers with the same therapy.

10-Apr-2006 1:45 PM EDT
Chemotherapy Advances Improve Outcomes in Select Breast Cancers
Dana-Farber Cancer Institute

Recent advances in chemotherapy have significantly reduced the risk of disease recurrence and death in breast cancer patients whose tumors are not hormone sensitive, according to a study by researchers at Dana-Farber Cancer Institute and 10 other institutions.

7-Apr-2006 4:50 PM EDT
Scientists Discover New Genetic Subtypes of Common Blood Cancer
Dana-Farber Cancer Institute

Scientists at Dana-Farber Cancer Institute and collaborators have identified four distinct genetic subtypes of multiple myeloma, a deadly blood cancer, that have different prognoses and might be treated most effectively with drugs specifically targeted to those subtypes.

Released: 23-Mar-2006 4:45 PM EST
Rituximab Effective in Treating Chronic Graft-Versus-Host Disease
Dana-Farber Cancer Institute

Dana-Farber researchers found that rituximab reduced the severity of chronic graft-versus-host disease (GVHD) in 70 percent of the study participants. Chronic GVHD is a potentially life-threatening complication of donor bone marrow and stem cell transplants.

Released: 19-Jan-2006 1:25 PM EST
Drug Combination Shows Promise for Treatment of Advanced Neuroendocrine Tumors
Dana-Farber Cancer Institute

A combination of an oral chemotherapy agent and a drug to prevent blood vessel growth has shown encouraging results in advanced neuroendocrine tumors, rare cancers of hormone-making cells that usually resist chemotherapy, researchers say.

13-Jan-2006 1:15 PM EST
New Cellular Flaw Found in Some Virulent Breast Cancers
Dana-Farber Cancer Institute

Researchers at Dana-Farber Cancer Institute have identified a molecular interaction that triggers a particularly aggressive form of breast cancer, and suggest that attacking this target with selective drugs might improve treatment.

Released: 28-Dec-2005 1:00 PM EST
Study IDs Way to Re-energize Immune Response to Chronic Viral Infection
Dana-Farber Cancer Institute

CD8 T cells eventually become "exhausted" in their battle against persistent viral infection, and less effective in fighting the disease. Dana-Farber and Emory University researchers have traced the problem to a gene that turns off the infection-fighting drive of CD8 T cells in mice.

Released: 14-Nov-2005 6:35 PM EST
Compound from Marine Bacteria Shows Potential as Multiple Myeloma Therapy
Dana-Farber Cancer Institute

An anti-cancer compound derived from bacteria dwelling in ocean-bottom sediments appears in laboratory tests to be a potent killer of drug-resistant multiple myeloma cells, and potentially with less toxicity than current treatments, report researchers.

20-Oct-2005 12:50 PM EDT
Despite Rarity of Errors in Chemotherapy Orders, Improvements Still Needed
Dana-Farber Cancer Institute

In one of the first studies to examine chemotherapy errors in ambulatory care for cancer patients, researchers have found that about three percent of chemotherapy orders in three outpatient infusion clinics studied contained mistakes.

18-Oct-2005 8:35 AM EDT
Dana-Farber: Herceptin Trial
Dana-Farber Cancer Institute

The targeted drug trastuzumab, or Herceptin, previously shown to prolong survival in advanced breast cancer, dramatically reduced the chances of recurrence in patients with early-stage disease when given for one year following standard chemotherapy.

Released: 12-Oct-2005 1:00 PM EDT
Double Trouble: Cells with Duplicate Genomes Can Trigger Tumors
Dana-Farber Cancer Institute

Abnormal cell division that yields cells with an extra set of chromosomes can initiate the development of tumors in mice, researchers have shown, validating a controversial theory about cancer causation put forth by a scientific visionary nearly 100 years ago.

23-Aug-2005 11:40 AM EDT
King George III’s Madness Linked to Key Metabolism Molecule
Dana-Farber Cancer Institute

Dana-Farber researchers say they have uncovered a molecular explanation for the episodic attacks of irrational and demented behavior in porphyria, the disease believed to have afflicted "Mad" King George III, the British ruler blamed for losing the American colonies.

5-Jul-2005 12:00 PM EDT
Scientists ID Gene Driving Melanoma Cell Growth and Survival
Dana-Farber Cancer Institute

A team of researchers led by scientists at Dana-Farber Cancer Institute have discovered a genetic abnormality in the cells of some advanced melanoma patients that worsens their chances of survival, but also might be a target of future drug attack against the dangerous skin cancer.

28-Jun-2005 12:25 PM EDT
DNA Scans Reveal Possible Location of Lung Cancer Genes
Dana-Farber Cancer Institute

Using single nucleotide polymorphism array technology, researchers at Dana-Farber Cancer Institute and collaborating institutions have found something much larger: sections of the chromosomes of lung cancer cells where cancer-related genes may lurk.

Released: 29-Jun-2005 11:25 AM EDT
Fire Up That Bar-B-Q! But Be Careful What You May Be Cooking Up
Dana-Farber Cancer Institute

Meat sizzling on the grill may tempt your taste buds, but all that barbecuing may be cooking up cancer-causing chemicals. Dana-Farber provides a few tips on how to grill more safely.

22-Jun-2005 3:20 PM EDT
Study Sheds Light on Genes Linked to Lung Cancer
Dana-Farber Cancer Institute

Dana-Farber researchers have identified nearly 100 chromosome regions where genes are either over-copied or missing in non-small cell lung cancer. The findings provide clues about the location of genes potentially linked to lung cancer and a range of possible therapeutic targets.

Released: 2-Jun-2005 1:05 PM EDT
Novel Combination Overcomes Drug-Resistant Myeloma Cells
Dana-Farber Cancer Institute

A novel strategy devised by Dana-Farber scientists has proved highly effective in killing drug-resistant multiple myeloma cells in the laboratory and could open a new form of attack on the deadly blood cancer, they report. The approach focuses on the proteasome and the aggresome.

Released: 18-Mar-2005 5:00 PM EST
City-Wide Prostate Cancer Screening and Education Initiative
Dana-Farber Cancer Institute

The Prostate Health Education Network and Dana-Farber Cancer Institute today announced a new city-wide prostate cancer screening and education initiative to combat the disease in African-American men, who are at the world's highest-risk for prostate cancer.

Released: 18-Feb-2005 1:10 PM EST
Designer Drug Is Potent Treatment for Chronic Myelogenous Leukemia
Dana-Farber Cancer Institute

A study has shown that a AMN107 "“ a compound discovered by and in development with Novartis Pharma AG - is about 20 times more potent than Gleevec in treating CML and is effective in treating Gleevec-resistant disease in model systems.

27-Jan-2005 9:50 AM EST
Blocking Cell Signaling Can Stymie Viral Infections, Approach to Smallpox Treatment
Dana-Farber Cancer Institute

Scientists at Dana-Farber Cancer Institute and collaborating institutions have shown that viruses can be prevented from infecting humans by interfering with signals viruses use to reproduce in human cells. The results point to a strategy for broadly treating acute viral infections.

24-Jan-2005 4:00 PM EST
Doctor-Patient Communication Can Reduce Medication-Related Problems
Dana-Farber Cancer Institute

Primary-care physicians who encourage their patients to let them know about bothersome side effects of prescribed medications "“"“ and who address such problems promptly "“"“ can reduce the chances that patients will be harmed by the medications, according to researchers in Boston.

Released: 7-Jan-2005 11:50 AM EST
Congressman’s Death Underscores Need for Research Into Blood Cancer Syndrome
Dana-Farber Cancer Institute

The recent death of Robert Matsui -- the 14-term Congressman from California who succumbed to myelodysplastic syndrome on Jan. 1 at the age of 63 -- has placed a national spotlight on a group of poorly understood and often incurable blood cancers.

21-Dec-2004 12:00 PM EST
Scientist Discover the Cellular Roots of Graying Hair
Dana-Farber Cancer Institute

Few things about growing older are as inevitable and obvious as "going gray," yet scientists have been unable to explain the precise cause of this usually unwelcome transformation. Researchers say they have found the cellular cause of graying hair.

Released: 20-Dec-2004 12:00 PM EST
Scientists Identify Protein Critical to Melanoma Growth
Dana-Farber Cancer Institute

Researchers at Dana-Farber Cancer Institute and Children's Hospital Boston have discovered that malignant melanoma, the potentially lethal skin cancer, can't grow without a steady supply of a protein that normal cells can do without.

Released: 3-Nov-2004 2:50 PM EST
Enhance Your Giving This Holiday Season
Dana-Farber Cancer Institute

Holiday giving to friends and family is both easier and more rewarding when gifts chosen give many ways "“ something the recipient can enjoy, yet something that also supports an important cause.

Released: 1-Nov-2004 2:30 PM EST
Grants to Develop Health Promotion, Prevention Programs in the Work Place
Dana-Farber Cancer Institute

The Center for Disease Control has awarded researchers at Dana-Farber Cancer Institute two grants totaling $3 million to develop workplace-based health promotion and prevention programs.

Released: 20-Oct-2004 1:00 PM EDT
Children’s Book Illustrators Decorate Snowflakes to Benefit Cancer Research
Dana-Farber Cancer Institute

It will be snowing art in November and December when original works"” decorated snowflakes"” by some of the best-known award-winning children's book illustrators will be auctioned online in a charity event, Robert's Snow: for Cancer's Cure.

14-Oct-2004 3:00 PM EDT
Childhood Cancer Survivors at Increased Risk of Breast Cancer
Dana-Farber Cancer Institute

Young women who were treated for cancer as children have a greater chance of developing breast cancer if their treatment included chest radiation, if they initially had cancer of the bones, muscles, or connective tissue, or had a family history of breast cancer, according to a new study.

Released: 20-Sep-2004 1:50 PM EDT
Leukemia Eliminated in Mice, Demonstrating New Cancer Drug Therapy
Dana-Farber Cancer Institute

Scientists at Dana-Farber Cancer Institute have corrected a flaw in cancer cells that lets them evade the normal cell-death process, and as a result they eliminated leukemia cells from mice.

Released: 30-Aug-2004 1:30 PM EDT
Lance Armstrong Foundation’s Gift Launches Adult Cancer Survivorship Clinic
Dana-Farber Cancer Institute

The Lance Armstrong Foundation has given a $1 million gift to Dana-Farber Cancer Institute to establish the Lance Armstrong Foundation Adult Survivorship Clinic. The clinic, which will be part of the Perini Family Survivors' Center, will expand Dana-Farber's commitment to serving cancer survivors of all ages.

Released: 19-Aug-2004 4:10 PM EDT
Cell-cycle Triggers Might be Cancer Drug Targets
Dana-Farber Cancer Institute

Dana-Farber Cancer Institute researchers have found that removing three key proteins believed essential to cell division and growth had little impact on normal tissue development of a mouse embryo.

12-Aug-2004 1:50 PM EDT
Hormonal Therapy Improves Survival in Prostate Cancer Patients
Dana-Farber Cancer Institute

Researchers have found that adding only six months of hormone therapy to external beam radiation therapy for localized prostate cancer increased patients' likelihood of surviving to five years by 10 percent.

15-Jul-2004 6:10 AM EDT
Study Suggests Broader Chemotherapy Attack in Breast Cancer
Dana-Farber Cancer Institute

In the first comprehensive survey of gene activity in each cell type composing normal and malignant breast tissue, scientists at Dana-Farber Cancer Institute have identified genes in non-cancerous supporting cells that can spur the growth of breast cancer cells.

6-Jul-2004 1:20 PM EDT
Drug Reduces Heart Damage Caused by Childhood Leukemia Treatment
Dana-Farber Cancer Institute

A potent chemotherapy that is highly effective in treating the most common form of childhood leukemia can significantly harm the heart, but findings from a multi-center study suggest that adding an experimental drug to the therapy can reduce or prevent the damage.



close
0.22429